Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma: Study Protocol for An International Multicenter Prospective Cohort Study (ENCRAM 2301)

NCT06273176 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06273176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06273176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma: Study Protocol for An International Multicenter Prospective Cohort Study (ENCRAM 2301)
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
January 1, 2028
Enrollment
225 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, malignant, brain neoplasms, brain neoplasms, adult, brain neoplasms, adult, malignant, glioblastoma, glioblastoma multiforme of brain, glioblastoma, idh-wildtype, recurrent adult brain tumor, recurrent glioblastoma